FDA Approves Pill for Metastatic Breast Cancer

Posted By on November 7th, 2017 at 10:06 am | 0 comments.

Patients with metastatic breast cancer have a new FDA-approved treatment option. Federal regulators approved the drug, Verzenio, which blocks enzymes that promote the growth of cancer cells for women with HR-positive, HER2-negative breast cancer. This new drug is targeted specifically for survivors who have not responded to hormone therapy.

To read the complete article, click here.


Comments are closed.